🔗 Share this article

As the United States continues making unprecedented adjustments to its vaccine schedules, an unexpected name has emerged in a surprising turn: Høeg, an American of Danish descent physician and epidemiologist who first made her name by casting doubt on Covid vaccines during the global health crisis and has concentrated on alleged deaths after Covid immunization in her recent position at the Food and Drug Administration.

Proposed Overhauls to Childhood Vaccine Schedule

Agency leaders had intended to unveil sweeping revisions to the pediatric vaccination calendar recently, aligning the US with Denmark’s national calendar, sources say – a significant shift that would place the US at odds with a large portion of the international standard with no evidence for benefit. The planned update has been delayed until the new year.

In place of Vinay Prasad, Dr. Høeg is set to address the audience at the gathering. She was recently named interim head of the FDA’s CDER, the fifth appointee to run the office this calendar year.

A Shift at the Agency

Høeg's temporary position may indicate a strengthened alliance between the drug and vaccine branches as Dr. Høeg and Dr. Prasad consolidate power at the FDA – and it points to a renewed priority upon dismantling already-approved immunizations at the FDA.

Dr. Høeg has frequently advocated for discontinuing some pediatric shot schedules in the US so as to align more like the Danish model, a society with universal health coverage and a citizenry roughly the population of the state of Wisconsin.

To date statements, she has persisted in emphasizing on vaccines – usually the purview of Dr. Prasad, chief of the FDA’s CBER – as opposed to medication approval.

Doubts Over Expertise

The appointee has little discernible track record in pharmaceutical research, oversight or management, which has been standard for past heads of the Center for Biologics Evaluation and Research. She has worked at the FDA as a top consultant to the FDA chief and the vaccine center since spring.

“She appears not to have the necessary background” for running the drug-regulation department, said a neurologist and psychiatrist. “She’s never run a scientific study. She lacks experience in running a large organization. She has no expertise in pharmaceutical oversight.”

Previous directors of the center would “understand laws and regulations and the research of pharmaceutical innovation”, commented a former acting FDA commissioner. “Frankly, she has not acquired the kind of background that previous people who led the center have had.”

CDER has an vast range of responsibilities at the FDA, the former commissioner stated.

“The public just pays attention on the new drug program, but the generic program authorizes a multitude of generic medications. There’s a biosimilars program, over-the-counter program and other areas, and every single one must be looked after,” she noted. “The responsibility you overlook, that’s the thing that I always told people is going to cause problems.”

There is also, a substantial management element to the job, which supervises more than 5,000 staff members. “It’s a massive administrative position, if you perform it correctly,” she said.

Agency Reaction and Disputed Programs

In response to questions about Dr. Høeg's fitness for the role and whether this appointment indicates more teamwork among agency officials on immunizations, a representative stated that the “concerns rely on incorrect assumptions”.

“Her experience aligns with the duties of her job,” the spokesperson said, citing the period Dr. Høeg spent counseling the FDA commissioner on “medication safety and approval science, including predictive safety algorithms and vaccine surveillance”.

In her interim role, Dr. Høeg assumes responsibility for the agency head's controversial expedited review system, a disputed one-day therapy clearance system that reportedly concerned her former heads. “How are these therapies being selected for this fast-track system? Who takes the choices?” Howard asked. “There’s a lot of confidentiality occurring at the FDA right now.”

In general, he remarked, “the Food and Drug Administration appears to be shifting towards less stringent regulations of most medications, except for shots.”

Documented Past Work on Vaccines

With immunizations, Høeg has a more documented, if problematic, history, Howard have noted. She released a study using unconfirmed crowd-sourced reports to estimate the rate of heart inflammation after Covid immunization. She advised the state of Florida surgeon general Dr. Joseph Ladapo, who reportedly have modified findings to indicate COVID-19 vaccinations are riskier than they are.

Included in her “desired changes” for the current government featured altering rules for novel immunizations and discontinuing “non-essential” vaccines, she remarked post-election on a online show. At the FDA, Høeg has reportedly floated the idea of barring adolescent males from obtaining COVID-19 vaccines.

“She is an all-around ideologue who commences with her conclusions and works backwards to accommodate the science in a very deceptive, dishonest manner,” Dr. Howard said.

Consolidating Power and a “Push for Payback”

Høeg joined other dissenters, {like|